Pacific-R
22 Dec 2020
Pacific-R
NCT03798535
First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy
AstraZaneca
Cancer Type | Lung & mesothelioma |
---|---|
Trial Type | Treatment |
Phase | All phases |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | - |
Cancer Stage | Locally Recurrent or Locally Advanced |
Anticipated Start Date | 2018-12-18 |
Anticipated End Date | 2023-12-01 |
Hospital | Calvary Central Districts Hospital |
---|---|
Clinical Trial Coordinator | Julie Rowe |
julie.rowe@calvarycare.org.au | |
Phone | 08 8239 9536 |
Principal Investigator | 08 8239 9536 |
Recruitment Status | Recruitment on Hold |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alex Scott-Hoy |
alex.scott-hoy@sa.gov.au | |
Phone | 08 8204 4830 |
Principal Investigator | Dr Shawgi Sukumaran |
Recruitment Status | Not Yet Recruiting |